InflaRx (IFRX) Total Liabilities (2016 - 2026)
InflaRx (IFRX) reported Total Liabilities of $19.52 million for Q3 2026, down 15.9% from $23.22 million a year earlier and down 17.5% from the prior quarter.
Powered by 
Analysis
InflaRx (IFRX) Total Liabilities (2016 - 2026) Analysis & Trends
At the end of FY2025, InflaRx posted Total Liabilities of $16.05 million, up 5.6% from FY2024.
- Total Liabilities has a five-year compound annual growth rate of 4.7% (FY2020 to FY2025).
- By year, Total Liabilities came in at $15.2 million in FY2024 (-22.1%), $19.51 million in FY2023 (+30.3%), $14.98 million in FY2022 (-33.4%) and $22.49 million in FY2021 (+76.6%).
- Five-year quarterly Total Liabilities spans a low of $8.43 million in Q1 2023 and a high of $23.67 million in Q2 2026.
- Year over year, Total Liabilities gained in five of the last eight quarters, with growth averaging 13.9%.
- The high point for year-over-year Total Liabilities in five years was Q1 2022 (growth of 126.2%); the low point was Q1 2023 (a decline of 62.2%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $23.67 million (Q2 2026), $13.75 million (Q1 2026) and $16.05 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 107.80 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 115.90 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 152.26 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 87.83 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 80.09 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 65.46 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 81.70 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 38.37 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 115.70 Bn |
| 10 | InflaRx | 85.79 Mn | -160.38 Mn | - | 16.05 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 19.52 Mn |
| Jun 30, 2026 | 23.67 Mn |
| Mar 31, 2026 | 13.75 Mn |
| Dec 31, 2025 | 16.05 Mn |
| Sep 30, 2025 | 23.22 Mn |
| Jun 30, 2025 | 19.23 Mn |
| Mar 31, 2025 | 17.90 Mn |
| Dec 31, 2024 | 15.20 Mn |
| Sep 30, 2024 | 16.09 Mn |
| Jun 30, 2024 | 11.65 Mn |
| Mar 31, 2024 | 13.32 Mn |
| Dec 31, 2023 | 19.51 Mn |
| Sep 30, 2023 | 12.14 Mn |
| Jun 30, 2023 | 9.04 Mn |
| Mar 31, 2023 | 8.43 Mn |
| Dec 31, 2022 | 14.98 Mn |
| Sep 30, 2022 | 11.48 Mn |
| Jun 30, 2022 | 13.06 Mn |
| Mar 31, 2022 | 22.28 Mn |
| Dec 31, 2021 | 22.49 Mn |
API Access
InflaRx Total Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-liabilities&ticker=IFRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-liabilities", "ticker": "IFRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-liabilities&ticker=IFRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();